Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,346.50 +208.37 1.38%
Hang Seng 23,474.00 +391.35 1.70%
S&P/ASX 200 5,224.30 +43.53 0.84%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Delta Lloyd L - Health Development Fund

+ Add to Watchlist

DELLHDA:LX

12.93 EUR 0.15 1.15%

As of 01:59:30 ET on 05/16/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Delta Lloyd L - Health Development Fund (DELLHDA)

Year To Date: +20.50% 3-Month: +12.83% 3-Year: +6.59% 52-Week Range: 9.88 - 13.08
1-Month: +4.02% 1-Year: +27.89% 5-Year: - Beta vs MXWO0IT: 0.72

Mutual Fund Chart for DELLHDA

No chart data available.
  • DELLHDA:LX 12.93
  • 1M
  • 1Y
Interactive DELLHDA Chart

Previous Close

Fund Profile & Information for DELLHDA

Delta Lloyd L - Health Development Fund is an open-end fund incorporated in Luxembourg. The Fund invests in companies that benefit structural changes in demographics and consumer behaviour and has its focus on the global healthcare market. The Fund focuses on innovative medical equipment, biotechnology, generic pharma, life science and diagnostics and emerging market healthcare.

Inception Date: 02-03-2010 Telephone: 352-49-324-1
Managers: NICOLE VAN SCHIE / KO VAN NIEUWENHUIJZEN
Web Site: www.deltalloyd.nl/beleggen

Fundamentals for DELLHDA

NAV (on 2013-05-16) 12.93
Assets (M) (on 2013-05-16) 29.55
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DELLHDA

No dividends reported

Fees & Expenses for DELLHDA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.49

Top Fund Holdings for DELLHDA

Filing Date: 02/28/2013
Name Position Value % of Total
Novartis AG 35,226 1,837,740 6.900%
Johnson & Johnson 19,483 1,134,242 4.258%
Pfizer Inc 53,984 1,130,181 4.243%
Alere Inc 56,933 991,162 3.721%
Celgene Corp 11,661 921,124 3.458%
Quality Systems Inc 64,883 919,137 3.451%
Teva Pharmaceutical Industries 30,391 869,410 3.264%
Shire PLC 35,929 861,462 3.234%
Sanofi 11,468 832,347 3.125%
Forest Laboratories Inc 29,266 823,795 3.093%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil